The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ivosidenib-Global Market Insights and Sales Trends 2024
Synopsis
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib market size is expected to reach US$ 238.5 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Ivosidenib in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Ivosidenib market. 60 Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30 Tablets segment is estimated at % CAGR for the next seven-year period.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ivosidenib, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ivosidenib market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ivosidenib market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ivosidenib sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ivosidenib covered in this report include Servier Pharmaceuticals. etc.
The global Ivosidenib market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Servier Pharmaceuticals
Global Ivosidenib market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ivosidenib market, Segment by Type:
60 Tablets
30 Tablets
Global Ivosidenib market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of IDH1, which is mutated in several forms of cancer.
The global Ivosidenib market size is expected to reach US$ 238.5 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Ivosidenib in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Ivosidenib market. 60 Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30 Tablets segment is estimated at % CAGR for the next seven-year period.
Ivosidenib's market driver is its efficacy in treating relapsed or refractory acute myeloid leukemia (AML) with IDH1 mutations. It inhibits the mutated IDH1 enzyme, leading to remission. The niche target population and limited treatment options contribute to its growth. However, challenges include potential side effects, the need for genetic testing to identify eligible patients, and competition from other AML therapies. Despite challenges, Ivosidenib's promising results and ongoing research in AML with IDH1 mutations present opportunities for market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ivosidenib, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ivosidenib market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ivosidenib market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ivosidenib sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ivosidenib covered in this report include Servier Pharmaceuticals. etc.
The global Ivosidenib market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Servier Pharmaceuticals
Global Ivosidenib market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ivosidenib market, Segment by Type:
60 Tablets
30 Tablets
Global Ivosidenib market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Ivosidenib Market Overview
1.1 Ivosidenib Product Overview
1.2 Ivosidenib Market Segment by Type
1.2.1 60 Tablets
1.2.2 30 Tablets
1.3 Global Ivosidenib Market Size by Type
1.3.1 Global Ivosidenib Market Size Overview by Type (2018-2029)
1.3.2 Global Ivosidenib Historic Market Size Review by Type (2018-2023)
1.3.3 Global Ivosidenib Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ivosidenib Sales Breakdown by Type (2018-2023)
1.4.2 Europe Ivosidenib Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Ivosidenib Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Ivosidenib Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Ivosidenib Sales Breakdown by Type (2018-2023)
2 Global Ivosidenib Market Competition by Company
2.1 Global Top Players by Ivosidenib Sales (2018-2023)
2.2 Global Top Players by Ivosidenib Revenue (2018-2023)
2.3 Global Top Players by Ivosidenib Price (2018-2023)
2.4 Global Top Manufacturers Ivosidenib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ivosidenib Market Competitive Situation and Trends
2.5.1 Ivosidenib Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Ivosidenib Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ivosidenib as of 2022)
2.7 Date of Key Manufacturers Enter into Ivosidenib Market
2.8 Key Manufacturers Ivosidenib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ivosidenib Status and Outlook by Region
3.1 Global Ivosidenib Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Ivosidenib Historic Market Size by Region
3.2.1 Global Ivosidenib Sales in Volume by Region (2018-2023)
3.2.2 Global Ivosidenib Sales in Value by Region (2018-2023)
3.2.3 Global Ivosidenib Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Ivosidenib Forecasted Market Size by Region
3.3.1 Global Ivosidenib Sales in Volume by Region (2024-2029)
3.3.2 Global Ivosidenib Sales in Value by Region (2024-2029)
3.3.3 Global Ivosidenib Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Ivosidenib by Application
4.1 Ivosidenib Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Ivosidenib Market Size by Application
4.2.1 Global Ivosidenib Market Size Overview by Application (2018-2029)
4.2.2 Global Ivosidenib Historic Market Size Review by Application (2018-2023)
4.2.3 Global Ivosidenib Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ivosidenib Sales Breakdown by Application (2018-2023)
4.3.2 Europe Ivosidenib Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Ivosidenib Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Ivosidenib Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Ivosidenib Sales Breakdown by Application (2018-2023)
5 North America Ivosidenib by Country
5.1 North America Ivosidenib Historic Market Size by Country
5.1.1 North America Ivosidenib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Ivosidenib Sales in Volume by Country (2018-2023)
5.1.3 North America Ivosidenib Sales in Value by Country (2018-2023)
5.2 North America Ivosidenib Forecasted Market Size by Country
5.2.1 North America Ivosidenib Sales in Volume by Country (2024-2029)
5.2.2 North America Ivosidenib Sales in Value by Country (2024-2029)
6 Europe Ivosidenib by Country
6.1 Europe Ivosidenib Historic Market Size by Country
6.1.1 Europe Ivosidenib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Ivosidenib Sales in Volume by Country (2018-2023)
6.1.3 Europe Ivosidenib Sales in Value by Country (2018-2023)
6.2 Europe Ivosidenib Forecasted Market Size by Country
6.2.1 Europe Ivosidenib Sales in Volume by Country (2024-2029)
6.2.2 Europe Ivosidenib Sales in Value by Country (2024-2029)
7 Asia-Pacific Ivosidenib by Region
7.1 Asia-Pacific Ivosidenib Historic Market Size by Region
7.1.1 Asia-Pacific Ivosidenib Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Ivosidenib Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Ivosidenib Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Ivosidenib Forecasted Market Size by Region
7.2.1 Asia-Pacific Ivosidenib Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Ivosidenib Sales in Value by Region (2024-2029)
8 Latin America Ivosidenib by Country
8.1 Latin America Ivosidenib Historic Market Size by Country
8.1.1 Latin America Ivosidenib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Ivosidenib Sales in Volume by Country (2018-2023)
8.1.3 Latin America Ivosidenib Sales in Value by Country (2018-2023)
8.2 Latin America Ivosidenib Forecasted Market Size by Country
8.2.1 Latin America Ivosidenib Sales in Volume by Country (2024-2029)
8.2.2 Latin America Ivosidenib Sales in Value by Country (2024-2029)
9 Middle East and Africa Ivosidenib by Country
9.1 Middle East and Africa Ivosidenib Historic Market Size by Country
9.1.1 Middle East and Africa Ivosidenib Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Ivosidenib Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Ivosidenib Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Ivosidenib Forecasted Market Size by Country
9.2.1 Middle East and Africa Ivosidenib Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Ivosidenib Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Servier Pharmaceuticals
10.1.1 Servier Pharmaceuticals Company Information
10.1.2 Servier Pharmaceuticals Introduction and Business Overview
10.1.3 Servier Pharmaceuticals Ivosidenib Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Servier Pharmaceuticals Ivosidenib Products Offered
10.1.5 Servier Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ivosidenib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ivosidenib Industrial Chain Analysis
11.4 Ivosidenib Market Dynamics
11.4.1 Ivosidenib Industry Trends
11.4.2 Ivosidenib Market Drivers
11.4.3 Ivosidenib Market Challenges
11.4.4 Ivosidenib Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ivosidenib Distributors
12.3 Ivosidenib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
